Graham Capital Management’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$368K	Buy	+41,120	New	+$328K	0.01%	728
2025 Q3	–	Sell	-234,614	Closed	-$1.18M	–	1694
2025 Q2	$1.18M	Buy	234,614 +119,499	+104%	+$641K	0.04%	536
2025 Q1	$746K	Buy	115,115 +33,865	+42%	+$301K	0.02%	647
2024 Q4	$596K	Buy	81,250 +45,335	+126%	+$358K	0.02%	674
2024 Q3	$269K	Buy	35,915 +23,321	+185%	+$203K	0.01%	818
2024 Q2	$112K	Buy	+12,594	New	+$121K	﹤0.01%	935
2024 Q1	–	Sell	-24,254	Closed	-$244K	–	1325
2023 Q4	$244K	Sell	24,254 -29,249	-55%	-$267K	0.01%	785
2023 Q3	$501K	Buy	+53,503	New	+$763K	0.02%	564
2022 Q4	–	Sell	-21,926	Closed	-$422K	–	1373
2022 Q3	$422K	Buy	+21,926	New	+$557K	0.02%	798
2022 Q2	–	Sell	-13,555	Closed	-$348K	–	1262
2022 Q1	$348K	Buy	+13,555	New	+$402K	0.02%	684